GANGRENOUS PYODERMA AS A RARE EXTRAHEPATIC MANIFESTATION OF SERONEGATIVE PRIMARY BILIARY CHOLANGITIS
Abstract
Background. A seronegative form of primary biliary cholangitis presents a diagnostic challenge, as it lacks serological markers and requires morphological verification. Cases of association between primary biliary cholangitis and pyoderma gangrenosum are rare. Objective. To describe a rare extrahepatic manifestation of pyoderma gangrenosum with scleroderma-like skin lesions in a patient with seronegative primary biliary cholangitis. Material and methods. We presented clinical observation data of patient V., aged 38 and treated in the gastroenterology department of the city clinical hospital. Results. The disease first manifested itself in cholestatic syndrome, accompanied by widespread ulcerative skin lesions on the hands and skin scleroderma-like changes. Blood tests revealed cytolysis and cholestasis. Markers for autoimmune liver diseases and hepatitis viruses were negative. Magnetic resonance cholangiopancreatography was normal. Liver morphology was characterized by minimal hepatitis and destructive cholangitis; ductular proliferation, cholestasis, and portal fibrosis were detected. Skin biopsy revealed scleroderma-like changes without vasculitis. Treatment with ursodeoxycholic acid, systemic glucocorticosteroids, and azathioprine resulted in ulcer epithelialization and normalization of biochemical parameters. Conclusion. Based on the examination, seronegative primary biliary cholangitis with extrahepatic manifestations – pyoderma gangrenosum – was diagnosed. The complexity of diagnosing necessitated a multidisciplinary approach and a comprehensive examination of the patient.
References
Rossijskoe obshchestvo po izucheniyu pecheni; Rossijskaya gastroenterologicheskaya associaciya; Associaciya revmatologov Rossii; Rossijskoe obshchestvo profilaktiki neinfekcionnyh zabolevanij; Rossijskoe nauchnoe medicinskoe obshchestvo terapevtov. Pervichnyj biliarnyj holangit. Proekt klinicheskih rekomendacij. Moskva; 2025. 190 p. (Russian).
Fennich FA, Kadiri M, Borahma M, Chabib FZ, Lagdali N, Berhili С, Elbarhdadi IB, Ajana FZ. Seronegative primary biliary cholangitis (PBC): epidemiological, clinical, therapeutic and evolutionary characteristics. Gut. 2024;73(Suppl 1):A256. https://doi.org/10.1136/gutjnl-2024-BSG.418.
Kögel J, Berneburg M, Karrer S, Drexler K, Niebel D. Multilokuläres Pyoderma gangraenosum : Assoziation mit der Erstmanifestation einer primär biliären Cholangitis [Multilocular pyoderma gangrenosum аssociation with primary manifestation of primary biliary cholangitis]. Die Dermatologie. 2023;74(7):538-542. https://doi.org/10.1007/s00105-023-05161-2. (German).
Rossijskoe obshhestvo dermatovenerologov i kosmetologov. Piodermiya gangrenoznaya. Klinicheskie rekomendacii. Moskva; 2025. 77 p. (Russian).
Associaciya revmatologov Rossii. Diagnostika i lechenie sistemnoj sklerodermii (progressiruyushchego sistemnogo skleroza). Klinicheskie rekomendacii. Moskva; 2013. 25 p. (Russian).
Benjouad K, Ouaya H, Boudda S, Errami AA, Oubaha S, Samlani Z, Krati K. Seronegative Primary Biliary Cholangitis: Epidemiological, Clinical, Therapeutic and Progressive Features. Cross Current Int J Med Biosci. 2020;2(9):131-132. https://doi.org/10.36344/ccijmb.2020.v02i09.003
Maev IV, Vinnitskaya EV, Reshetnyak VI. Pervichnyj biliarnyj holangit: istoricheskie aspekty [Primary biliary cholangitis: historical aspects]. Jeffektivnaja farmakoterapija [Effective Pharmacotherapy]. 2025;21(31):56-69. https://doi.org/10.33978/2307-3586-2025-21-31-56-69. https://elibrary.ru/ssgflj. (Russian).
Khatkov IE, Vinnitskaia EV, Efanov MG, Nedoluzhko IYu, Kulezneva YuV, Melekhina OV, Homeriki SG, Gudkova RB; Khatkov IE, Vinnitskaia EV, editors. Pervichnyj skleroziruyushchij holangit. Vzglyad terapevta i hirurga. Moskva: Litterra; 2019. 184 p. edn: FNZXLQ. (Russian).
Prathibha JP, Madhukara J, Bhat PI, Gowda I. Unresolved malady of pyoderma gangrenosum: A study of its profile and outcome in a tertiary care center. Clinical Dermatology Review. 2024;8(2):113-119. https://doi.org/10.4103/cdr.cdr_113_22.















1.png)


